2024 年 41 巻 3 号 p. 280-281
The Neurotherapeutic Society, aiming to improve treatments for neurological diseases, established a Drug Discovery Promotion Committee which conducted a survey from October 17 to November 5, 2022, to gauge member opinions on society functions and support. The web–based survey, which received 113 responses, gathered insights on previous R&D experiences, support received from various organizations, and desired roles and support from the society. Most respondents were involved in research and clinical practice. Key feedback indicated a preference for support from Academic Research Organizations (AROs) and a need for help in development planning, obtaining research funding, and educational programs for researchers. Additional suggestions included improving patient recruitment, promoting societal contributions through drug development, and enhancing interactions with pharmaceutical entities and regulatory bodies. The committee will use these findings to inform future support initiatives for the society.
